Theodorus Investment Funds

At Supernova Invest, we believe that top scientists and ambitious entrepreneurs can build a world where cutting-edge technologies shape the next generation of industry leaders. Our team provides unparalleled expertise and patient capital in the fields of healthcare, energy and environment, Industry 4.0, and digital technologies to support high-growth, deeptech start-ups and scale them globally. Leader and pioneer in DeepTech investment from inception to maturity. Supernova Invest’s founding team has more than 20 years of experience in deeptech venture capital. The company emerged in 2017 from the alliance between Amundi (Crédit Agricole Group) and the CEA, a key player in technological research. Supernova Invest is an independent management company, investing mainly across Europe. Investment decisions are made by the partners on the Investment Committee. With a total of about 100 investments and more than 70 portfolio companies, Supernova Invest benefits from a unique track record in deeptech, as reflected in its 30+ successful trade exits. The Supernova Invest team combines the best of technology and financing. What sets us apart is our ability to understand both the underlying technologies and the most complex deep tech business models. Our sectorsINDUSTRY 4.0 Engineering tools Production tools Embedded systems Logistics HEALTHCARE Medtech Biotech Diagnostics Discovery Tools DIGITAL TECHNOLOGIES Computing Semiconductors Cybersecurity Telecom ENERGY & ENVIRONMENT Cleantech Energy Transition Agritech Foodtech Our operating partners platform Supernova Invest collaborates with a selection of Operating Partners in order to industrialize our value-add support to our portfolio startups and facilitate the adoption of deeptech best practices. This program is an illustration of the Supernova Invest platform for Entrepreneurs, dedicated to the deeptech-specific challenges that they experience in scaling their startups. In the ever-growing landscape of deeptech funds, these operating partners incarnate our investor singularity as the pioneer and deep-tech leading VC firm. They were carefully selected, leveraging our unique understanding of deeptech-specific challenges and our join track record in getting deeptech startup to thrive. They embrace a one-of-kind, extensive scope of critical expertise to provide our entrepreneurs with the most elaborated deeptech support platform. The selection is the spearhead of a much wider network for fine-grained, custom-made support.

We are a European family office owned fund; we understand biosciences and medical technologies better than anyone else in the Private Equity and Venture Capital ecosystem. The capital of this fund has been generated by the family office's active bioscience investments across Europe, USA, and the APAC region since 1995. We understand the intricacies of commercializing bioscience discoveries. We also acknowledge that bioscience venture leadership requires deep courage - from founders and the investors that back them. What we look for We operate globally and only review investment opportunities submitted to us by our partner investment banks across the globe. If we believe in the transformative power of the discovery and the founder's ambition, this will suffice for us to determine the venture's potential. Our approach Upon receipt of a proposal from our investment bank partners, we will analyze the proposed deal, meet with the venture founders, and understand their vision. We will propose a deal size and structure. Execute a letter of intent and perform appropriate due diligence, negotiate, and execute a mutually acceptable binding contract. Release the required funding, close the transaction and work together to grow the business.

We look for companies in Italy and selectively abroad. 5 KEY SECTORS Founded in 2016, today Indaco Venture Partners SGR is the largest independent Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics, robotics and new materials, medtech, biotech – pharma and digital. EXPERIENCE The investment team managers have an extensive experience in venture investing in Italy and abroad and have executed a high number of successful exits, including IPOs and transactions with corporate partners.

Wir sind der neue Frühphasen-Investor aus Mecklenburg-Vorpommern. Wir lieben Innovationen made by Founders in MV Und wir glauben an folgende Themen: Gesundheit & Pharma: Die globale Corona-Pandemie hat uns gezeigt, wie wertvoll Investitionen in unsere Gesundheit sind. Das haben wir verstanden. Bioökonomie & Agrarwirtschaft: Vor unserer Haustür wachsen viele natürliche Rohstoffe, die eine innovative und biobasierte Wirtschaft antreiben. Das gefällt uns. Nachhaltigkeit: Greentech ist der Schlüssel für eine saubere Zukunft. Das sehen wir auch und werden hier unseren Beitrag als Investor leisten. Unser Investmentfokus in a Nutshell Phase: Early-Stage Ticketgröße: EUR 100-300k Bereich: Agrar, Gesundheit, Pharma, Nachhaltigkeit, Digital Region: Mecklenburg-Vorpommern

We are engineers, developers, scientists and business people – but we‘re all entrepreneurs. We meet you at eye level and do whatever is takes to help you achieving your goals. Strategy, product development, regulatory, hiring or sales – we use our hands and brains for you and your team to become successful. Becoming the next category leader doesn‘t come for free. We fuel your ambition by investing early-stage venture capital. For a reliable long-term relation, we invest early and have a decent reach to support you on your journey. Our international network backs your later rounds. Authentic early-stage investing takes a lot of work and time. We believe that real human-to-human interaction is the key to successful long-term relationships. We are here for you when you need us and at your site if you call for us. That‘s why we mainly invest in teams that we can reach within two hours. Brain We invest in startups, we can offer more than a money investment. That is why we always have a peer on our team who understands your customers, knows your market and feels you dealing with your challenges. We want to be real value-add. Having a long VC history, we gathered a lot of experience in building successful companies. We support you hands on in all your challenges, organize workshops with experts and connect with our numerous partners. Whether it’s first key hires, adapting corporate strategy, support with approval processes and reimbursement or setting up a sales playbook – we are familiar with the many challenges that you as startups face and help to overcome them more quickly. Cash We are an early-stage VC dedicated to investing in technology companies that have the potential to enable or disrupt major industries. Our strategy centers on getting involved early, primarily focusing on Seed stages, with occasional Series A initial investments. We only invest in cases in which we are confident to take the lead, but we don’t always have to do so. We feel comfortable in strong consortia with other VCs and business angels. Technology plays the keyrole in tackling the most pressing challenges of our time and in improving people’s working and living conditions. We work with the best entrepreneurial teams and visionaries, capable of crafting transformative technology. We are a b2b investor. Our focus spans across SaaS/software, IoT, digital solutions, medtech, biotech, new materials and greentech/cleantech. We invest in ventures with a convincing technology core providing strong competitive edge and serving important customers needs. STAGES: (Pre-) Seed | Series A AUM: > 100 Mio. € INITIAL TICKET: 500k € - 2,0 Mio. € MAX AMOUNT: 6,0 Mio. € Proximity We are an ecosystem player, providing a strong regional presence and deep-rooted network. It‘s a crucial part of our mission to offer hands-on support and be there in person when we are needed. We want to keep our approach authentic and reliable. That‘s why we focus our investment activities within a rough two-hour reach from us – that‘s Rhineland area (Germany) and neighbouring Netherlands and Belgium. Given a strong fit and extra conviction, we’re open to investments across whole Germany. The early stages are the period for a startup in which future success is defined. Finding product-market fit and an effective go-to-market strategy early are keys to market dominance. We‘re passionate about sharing our insights in that. The critical role of frequent social interaction cannot be overstated. Network and access are among the most crucial offerings an investor can provide. We facilitate exclusive interaction wtih the established economy via the S-UBG Group, giving young startups access to their first potential customers or partners. The network includes over 150 SME companies resulting from 30 years of investment experience of S-UBG.

The MBVF is a collaborative effort between the U-M Medical School’s Fast Forward Medical Innovation (FFMI) program and the U-M College of Engineering’s Center for Entrepreneurship (CFE). Founded based on an initial gift from the Monroe-Brown Foundation, MBVF makes seed-stage equity investments in UM life science startup companies, typically $100,000-$300,000. This evergreen fund serves to drive the university’s world-class leadership by creating a critical pipeline between research and the biomedical innovation life cycle, resulting in broad clinical and economic impact through startups. The Fund is exclusively for biomedical startups with U-M IP. Most applicants need to successfully complete an existing U-M translational program such as Coulter, MTRAC for Life Sciences, NSF I-Corps. Companies interested in more information should consult with the Fund Manager.